Oakbrook Terrace, Illinois (January 25, 2024) – Bimeda, Inc. has recently launched BOVitalize™ in the US. BOVitalize is an oral vitamin and mineral supplement for beef and dairy cows, bulls and rumina...

Bimeda Holdings Chairman, Donal Tierney, Minister for Enterprise, Trade and Employment, Simon Coveney TD, and Professor Helen Roche, interim UCD Vice-President for Research, Innovation and Impact toda...

Oakbrook Terrace, Illinois (July 19, 2023) – Bimeda Inc. is pleased to announce that SpectoGard (spectinomycin sulfate) Sterile Solution—which received FDA approval in September of 2022—is now availab...

Bimeda is pleased to announce the appointment of Jim Lovin as a Strategic Accounts Manager - Swine. Jim will focus on the development and management of both core Bimeda products and custom vaccine lin...

Bimeda® Inc. is thrilled to announce their new partnership with The Spirit of Hagyard podcast. Created in 2022, the podcast was developed by Hagyard Equine Medical Institute, a renowned equine veterin...

Bimeda is pleased to announce the launch of the company's first Annual Sustainability Report. The report is now available to read and download on onebimeda.com In early 2022, Bimeda announced the laun...

Global veterinary pharmaceutical and animal health specialist Bimeda has announced its latest significant investment, via the acquisition of South Africa's leading animal health distributor, Afrivet S...

Bimeda is pleased to announce the launch of a new sustainability-focused website, onebimeda.com. The website details Bimeda's sustainability mission statement and the five Sustainability Pillars which...

Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...

Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...

Bimeda® Inc. announced the launch of Detomidine Hydrochloride, a sedative and analgesic used to facilitate minor surgical and diagnostic procedures in mature horses and yearlings, to veterinarians. Th...

It is my pleasure to announce the promotion of David Ellefson, D.V.M. to the newly created position of Senior Director, Technical Services North America. Dr. Dave has been employed with Bimeda for the...

Dear Customers, Distributors and Retailers, Bimeda received communication from the Food and Drug Administration's (FDA) Center for Veterinary Medicine (CVM) regarding continued concerns that people ar...

Bimeda is pleased to announce the acquisition of AquaTactics Fish Health ("AquaTactics"), based in Seattle, Washington. The company was founded in 2009 by Dr Tom Goodrich and Hugh Mitchell DVM. The co...

Bimeda® is pleased to announce the appointment of Ben Siegfried as a Regional Strategic Sales Manager for the states of Nebraska and Iowa. Ben will be an integral part of the livestock sales team and ...

Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim ...

Bimeda is pleased to announce the launch of Macrosyn (tulathromycin injection) 100mg/mL. Macrosyn is a ready-to-use injectable solution containing 100 mg of tulathromycin/mL, a broad spectrum, fast-ac...

We would like to congratulate Stephanie Batliner, Director of Regulatory Affairs of North America, on her election to the role of Chair of GADA (Generic  Animal Drug Alliance). We would like to c...

Following consistent growth and popularity of Bimeda® lnc.'s Confidence EQ®, the parent company announced plans to expand marketing efforts and packaging options today for the equine appeasing ph...

We welcome Dr. Paul Lawrence as the Research and Development Director for Bimeda Biologicals. Dr. Lawrence will manage and provide strategic direction in the development of USDA approved products and ...